Navigation Links
Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
Date:5/9/2008

DANBURY, Conn., May 9 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for its second quarter ended March 31, 2008. The net loss for the quarter was $9.6 million or $0.43 per share.

"We remain on track in our development of VIAject(TM)," stated Dr. Solomon Steiner, CEO and Chairman of Biodel. "The last patient visits for both pivotal Phase III clinical trials are scheduled to occur in July. We expect to announce top line data late in the third or early in the fourth calendar quarter of 2008 and to submit our New Drug Application in December. Like all three approved rapid acting insulins, and at the request of the FDA, VIAject(TM)'s pivotal studies are against regular human insulin. We believe VIAject(TM)'s ultra rapid PK/PD profile will produce comparative safety and weight advantages against regular human insulin that have never before been demonstrated by any meal-time insulin. In addition, our market research suggests VIAject(TM)'s existing Phase I and Phase II comparative data against Humalog(R), coupled with successful Phase III data, will lead physicians to prescribe VIAject(TM) to both new patients and patients suffering from frequent hypoglycemic events."

Three Months Ended March 31, 2008

Biodel reported no revenue during the three months ended March 31, 2008 and March 31, 2007.

Biodel reported a net loss for the three months ended March 31, 2008 of $9.6 million, or $0.43 per share, as compared to a net loss applicable to common stockholders of $9.7 million, or $1.79 per share, for the comparable period in the prior year. Net loss for the quarter ended March 31, 2007 included a $4.5 million deemed dividend charge. Net loss for the quarter ended March 31, 2008 includes $1.7 million of stock-based compensation expenses. The stock-based compensation charge includes $0.5 million of stock-based compensation charges for options awarded annually to the board of directors.

Research and de
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
2. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
3. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
4. Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007
5. Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007
6. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
7. Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007
8. Biodel Inc. Announces Pricing of Public Offering
9. Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008
10. Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results
11. Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... 2014 2013 was a banner year ... Technologies®. They saw continued independent research led by the ... awarded a $1 million grant from the Susanne Marcus ... Behavior” a peer reviewed journal, Amy Grant highlighted Brainwave ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... Broad Expertise and Strong Leadership Skills in ... Jan. 9 BioNanomatrix, Inc., a developer ... personalized medicine and biomedical research, today announced ... president of engineering. Mr. Kochersperger has ...
... CAMBRIDGE, Mass. January 8, 2008 From the ... galaxies, helical forms are as abundant as they are ... Harvard School of Engineering and Applied Sciences (SEAS) have ... of nanobristles, akin to tiny hairs, into helical clusters ...
... of The IN VIVO Blog , which provides news, ... have selected a Deal of the Year for ... Pharmaceuticals .More than 2,500 reader votes were cast in this ... finish among the 13 nominees selected by The IN VIVO ...
Cached Biology Technology:BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering 2BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering 3Researchers control the assembly of nanobristles into helical clusters 2The IN VIVO Blog Selects First Annual 'Deal of the Year' 2
(Date:4/17/2014)... the process whereby the genetic information of DNA ... proteins, which have numerous different functions in living ... intermediary during gene expression, by relating the genetic ... in manufacturing proteins. , By examining the ... in an organism at a given time, researchers ...
(Date:4/17/2014)... way the immune system may fight cancers and viral ... cells to treat illness. , The research, in mice, ... "neighborhood police" specialized squads of defenders that patrol ... entire city, the body. , Scientists at Washington University ... the liver, skin and uterus each has dedicated immune ...
(Date:4/17/2014)... about domestication derive from Charles Darwin, whose ideas ... practices during the 19th century, a period when ... It is from Darwin that we inherit the ... from wild species and total human control over ... in this industrial setting has been applied too ...
Breaking Biology News(10 mins):Rapid and accurate mRNA detection in plant tissues 2Some immune cells defend only 1 organ 2The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4
... Bacteria don,t have easy lives. In addition to mammalian ... called bacteriophages, viruses that kill half the bacteria on Earth ... of microorganisms called archaea (first discovered in extreme environments such ... part because they have a built-in defense system that helps ...
... of a lifetime, the heart pumps some 250 million liters ... this, the muscle fibers of the heart have to be ... vice chair of the Department of Medicine III at Heidelberg ... a protein that is responsible for the stability of the ...
... 12 new grant recipients for 2009. The awards, totaling ... of lupus research. All were selected for their creativity, ... prevent, treat, and cure the complex disease of systemic ... and established lupus researchers across the nation and include ...
Cached Biology News:Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3
Request Info...
Request Info...
Request Info...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: